Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

An engineered protein antagonist of K-Ras/B-Raf interaction

Open access

Abstract

Ras is at the hub of signal transduction pathways controlling cell proliferation and survival. Its mutants, present in about 30% of human cancers, are major drivers of oncogenesis and render tumors unresponsive to standard therapies. Here we report the engineering of a protein scaffold for preferential binding to K-Ras G12D. This is the first reported inhibitor to achieve nanomolar affinity while exhibiting specificity for mutant over wild type (WT) K-Ras. Crystal structures of the protein R11.1.6 in complex with K-Ras WT and K-Ras G12D offer insight into the structural basis for specificity, highlighting differences in the switch I conformation as the major defining element in the higher affinity interaction. R11.1.6 directly blocks interaction with Raf and reduces signaling through the Raf/MEK/ERK pathway. Our results support greater consideration of the state of switch I and provide a novel tool to study Ras biology. Most importantly, this work makes an unprecedented contribution to Ras research in inhibitor development strategy by revealing details of a targetable binding surface. Unlike the polar interfaces found for Ras/effector interactions, the K-Ras/R11.1.6 complex reveals an extensive hydrophobic interface that can serve as a template to advance the development of high affinity, non-covalent inhibitors of K-Ras oncogenic mutants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-05889-7

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Engineered Sso7d protein selectively binds mutant K-Ras. (a) Amino acid sequences of parental binder R11.1 and affinity-matured clones. The nine residues of the Sso7d binding surface are depicted in blue; R11.1 framework mutations are shown in red. Dissociation constants (Kd) obtained from yeast surface display (YSD) titrations detected using flow cytometry are given on the right. (b) YSD titrations of R11.1.6 with K-Ras loaded with GDP or the non-hydrolyzable GTP analog GppNHp. Error bars represent SEM of n = 3 independent binding experiments. (c,d) Binding of R11.1.6 to immobilized GppNHp-loaded K-Ras, H-Ras, or N-Ras measured using bio-layer interferometry. Concentrations of R11.1.6 curves from dark to light: 1000, 333.3, 111.1, 37, 12.3, 4.1, 1.4 nM. Kd values were calculated from steady-state values.
Figure 1 Engineered Sso7d protein selectively binds mutant K-Ras. (a) Amino acid sequences of parental binder R11.1 and affinity-matured clones. The nine residues of the Sso7d binding surface are depicted in blue; R11.1 framework mutations are shown in red. Dissociation constants (Kd) obtained from yeast surface display (YSD) titrations detected using flow cytometry are given on the right. (b) YSD titrations of R11.1.6 with K-Ras loaded with GDP or the non-hydrolyzable GTP analog GppNHp. Error bars represent SEM of n = 3 independent binding experiments. (c,d) Binding of R11.1.6 to immobilized GppNHp-loaded K-Ras, H-Ras, or N-Ras measured using bio-layer interferometry. Concentrations of R11.1.6 curves from dark to light: 1000, 333.3, 111.1, 37, 12.3, 4.1, 1.4 nM. Kd values were calculated from steady-state values.CC BY · PubMed Central
Figure 2 Switch I conformation gives rise to R11.1.6 mutant-specific binding. (a) Overlay of co-crystal structures of R11.1.6 with GppNHp-bound K-Ras WT and G12D. The C-terminus of R11.1.6 in both structures is partially disordered. (b) Binding interface between R11.1.6 (magenta) and K-Ras G12D (green) at switch II, highlighting the hydrophobic pocket created upon complex formation. K-Ras G12D residues are indicated in regular font; R11.1.6 residues are shown in italics. (c) Interactions between R11.1.6 lysine residues and K-Ras that give rise to greater affinity for the G12D mutant over WT. Bond distances of less than 4.0 Å are shown in dashed lines. A water molecule is shown as a blue sphere.
Figure 2 Switch I conformation gives rise to R11.1.6 mutant-specific binding. (a) Overlay of co-crystal structures of R11.1.6 with GppNHp-bound K-Ras WT and G12D. The C-terminus of R11.1.6 in both structures is partially disordered. (b) Binding interface between R11.1.6 (magenta) and K-Ras G12D (green) at switch II, highlighting the hydrophobic pocket created upon complex formation. K-Ras G12D residues are indicated in regular font; R11.1.6 residues are shown in italics. (c) Interactions between R11.1.6 lysine residues and K-Ras that give rise to greater affinity for the G12D mutant over WT. Bond distances of less than 4.0 Å are shown in dashed lines. A water molecule is shown as a blue sphere.CC BY · PubMed Central
Figure 3 R11.1.6 reduces K-Ras intrinsic hydrolysis but directly competes with Raf. (a) Overlay of the co-crystal structure of R11.1.6 with K-Ras G12D with structures of K-Ras G12D in complex with a small molecule (PDB ID 4DSN) and H-Ras WT (PDB ID 4G0N), showing the disruption of Y32 and Q61 by R11.1.6, with an open switch I conformation. (b) Intrinsic hydrolysis rate constants (khyd) of K-Ras alone or in the presence of R11.1.6 and/or the Ras binding domains (RBD and CRD, residues 51–196) of Raf. Error bars represent SEM of n = 3 independent experiments. **P < 0.01, 1-way ANOVA with Tukey post-test for analyzing all possible comparisons. (c) Overlay of the co-crystal structure of R11.1.6 with K-Ras G12D with the co-crystal structure of H-Ras WT with Raf RBD (PDB ID 4G0N). (d) Schematic representation of yeast surface display competition assay between R11.1.6 and Raf RBD for K-Ras binding. (e) Competition for binding of K-Ras as depicted in (d). Error bars represent SEM of n = 3 independent binding experiments.
Figure 3 R11.1.6 reduces K-Ras intrinsic hydrolysis but directly competes with Raf. (a) Overlay of the co-crystal structure of R11.1.6 with K-Ras G12D with structures of K-Ras G12D in complex with a small molecule (PDB ID 4DSN) and H-Ras WT (PDB ID 4G0N), showing the disruption of Y32 and Q61 by R11.1.6, with an open switch I conformation. (b) Intrinsic hydrolysis rate constants (khyd) of K-Ras alone or in the presence of R11.1.6 and/or the Ras binding domains (RBD and CRD, residues 51–196) of Raf. Error bars represent SEM of n = 3 independent experiments. **P < 0.01, 1-way ANOVA with Tukey post-test for analyzing all possible comparisons. (c) Overlay of the co-crystal structure of R11.1.6 with K-Ras G12D with the co-crystal structure of H-Ras WT with Raf RBD (PDB ID 4G0N). (d) Schematic representation of yeast surface display competition assay between R11.1.6 and Raf RBD for K-Ras binding. (e) Competition for binding of K-Ras as depicted in (d). Error bars represent SEM of n = 3 independent binding experiments.CC BY · PubMed Central
Figure 4 R11.1.6 specifically binds K-Ras G12D in cells, blocks K-Ras-B-Raf interaction, and inhibits signaling. (a) Co-localization of EGFP-R11.1.6 (green) with mApple-K-Ras G12D (red) in co-transfected HEK 293T cells. Scale bars are 10 μm. Images are representative of n = 2 biological replicates. Co-localization is quantified in Extended Data Figure 5a. (b) Co-immunoprecipitation of HA-tagged K-Ras G12D with cmyc-R11.1.6/YW1 in co-transfected HEK 293T cells, showing R11.1.6 specificity for K-Ras G12D. IP, immunoprecipitation; WCL, whole cell lysate. Results are representative of n = 2 biological replicates. (c) Co-immunoprecipitation of endogenous B-Raf with HA-tagged K-Ras G12D in co-transfected HEK 293T cells, showing inhibition of K-Ras-B-Raf binding by R11.1.6. Results are representative of n = 3 biological replicates. (d) Effect of R11.1.6 on phosphorylation of endogenous MEK (pMEK) and ERK (pERK) via HA-K-Ras G12D-induced signaling in co-transfected HEK 293T cells, showing inhibition of signaling by R11.1.6. Results are representative of n = 3 biological replicates. Quantification is provided in Extended Data Figure 5e. Full-length blots of the cropped ones shown here are given in Extended Data Figures 6, 7, and 8.
Figure 4 R11.1.6 specifically binds K-Ras G12D in cells, blocks K-Ras-B-Raf interaction, and inhibits signaling. (a) Co-localization of EGFP-R11.1.6 (green) with mApple-K-Ras G12D (red) in co-transfected HEK 293T cells. Scale bars are 10 μm. Images are representative of n = 2 biological replicates. Co-localization is quantified in Extended Data Figure 5a. (b) Co-immunoprecipitation of HA-tagged K-Ras G12D with cmyc-R11.1.6/YW1 in co-transfected HEK 293T cells, showing R11.1.6 specificity for K-Ras G12D. IP, immunoprecipitation; WCL, whole cell lysate. Results are representative of n = 2 biological replicates. (c) Co-immunoprecipitation of endogenous B-Raf with HA-tagged K-Ras G12D in co-transfected HEK 293T cells, showing inhibition of K-Ras-B-Raf binding by R11.1.6. Results are representative of n = 3 biological replicates. (d) Effect of R11.1.6 on phosphorylation of endogenous MEK (pMEK) and ERK (pERK) via HA-K-Ras G12D-induced signaling in co-transfected HEK 293T cells, showing inhibition of signaling by R11.1.6. Results are representative of n = 3 biological replicates. Quantification is provided in Extended Data Figure 5e. Full-length blots of the cropped ones shown here are given in Extended Data Figures 6, 7, and 8.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 65

Metadata

Authors
Kauke, M. J., Traxlmayr, M. W., Parker, J. A., Kiefer, J. D., Knihtila, R., McGee, J., Verdine, G., Mattos, C., & Wittrup, K. D.
Affiliations
  • Koch Institute for Integrative Cancer Research At MIT (US)
  • Northeastern University (US)
  • ETH Zurich (CH)
  • Harvard University (US)
Corresponding author
Wittrup, K. Dane
Venue
Scientific Reports
Published
2017-07-19
Volume
7
Issue
1
Pages
5831-5831
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2734751189
Cited by
64
References
30
Citations by year
2025: 5 · 2024: 4 · 2023: 6 · 2022: 9 · 2021: 5 · 2020: 12 · 2019: 9 · 2018: 9 · 2017: 5
FWCI
3.91
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
  • Nature
  • ETH Zürich Research Collection (cc-by)
Funders
  • National Science Foundation (P30-CA14051, 1228897, 0070319, 1517295)
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (P30-CA14051, Grant P30-CA14051)
  • Austrian Science Fund (P30-CA14051, J 3496)
  • National Institutes of Health (0070319, 5-R01-, 1s10od016326-01a1)
  • National Cancer Institute (CA96504, CA14051, CA174795, R01CA096504, Koch Institute Support (core) Grant P30-CA14051, CA096504, R01CA174795, Grant P30-CA14051, P30CA014051, P30-CA-14051)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
KRAS G12D, BRAF, hydrophobic interface, MAPK/ERK pathway, RAS inhibitors, cancer therapy resistance, crystal structure
MeSH terms
Amino Acid Sequence, Humans, Mutation, Protein Binding, Recombinant Proteins, Protein Engineering, ras Proteins, Mutant Proteins, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An engineered protein antagonist of K-Ras/B-Raf interaction. https://app.cochat.ai/papers/10.1038/s41598-017-05889-7
The paper
Kauke, M. J., Traxlmayr, M. W., Parker, J. A., Kiefer, J. D., Knihtila, R., McGee, J., Verdine, G., Mattos, C., & Wittrup, K. D. (2017). An engineered protein antagonist of K-Ras/B-Raf interaction. Scientific Reports. https://doi.org/10.1038/s41598-017-05889-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.